HBW
TMO icon

Hazlett, Burt & Watson’s Thermo Fisher Scientific TMO Stock Holding History

Hazlett, Burt & Watson’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Buy
2,052
+88
+4% +$47.8K 0.31% 80
2025
Q4 		$1.14M Buy
1,964
+244
+14% +$138K 0.36% 64
2025
Q3 		$836K Sell
1,720
-40
-2% -$18.6K 0.3% 77
2025
Q2 		$714K Buy
1,760
+233
+15% +$97.4K 0.29% 80
2025
Q1 		$756K Buy
1,527
+47
+3% +$25.5K 0.34% 68
2024
Q4 		$771K Buy
1,480
+101
+7% +$55.5K 0.34% 69
2024
Q3 		$854K Buy
1,379
+75
+6% +$44.4K 0.39% 58
2024
Q2 		$721K Buy
1,304
+106
+9% +$60.7K 0.37% 61
2024
Q1 		$698K Sell
1,198
-55
-4% -$30.9K 0.42% 49
2023
Q4 		$668K Sell
1,253
-56
-4% -$27.1K 0.45% 47
2023
Q3 		$668K Sell
1,309
-306
-19% -$163K 0.5% 39
2023
Q2 		$845K Sell
1,615
-97
-6% -$52.3K 0.63% 23
2023
Q1 		$988K Buy
1,712
+55
+3% +$31K 0.81% 22
2022
Q4 		$917K Sell
1,657
-2
-0.1% -$1.06K 0.81% 24
2022
Q3 		$845K Hold
1,659
– – 0.82% 21
2022
Q2 		$902K Buy
1,659
+30
+2% +$16.5K 0.83% 22
2022
Q1 		$960K Buy
+1,629
New +$936K 0.76% 25

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hazlett, Burt & Watson's TMO Position: Q1 2026 in Review

Hazlett, Burt & Watson increased its Thermo Fisher Scientific (TMO) stake by 4.5% in Q1 2026, buying an estimated $47.8K and bringing the position to 2,052 shares worth $1M. The position accounts for 0.31% of the portfolio, ranked #80.

Hazlett, Burt & Watson first reported a position in TMO in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.14M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Hazlett, Burt & Watson held 2,052 shares of Thermo Fisher Scientific worth $1M as of Q1 2026.
  • Hazlett, Burt & Watson bought 88 Thermo Fisher Scientific shares in Q1 2026, an estimated $47.8K.
  • Thermo Fisher Scientific made up 0.31% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #80 holding.
  • Hazlett, Burt & Watson first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 17 quarters since.
  • Hazlett, Burt & Watson's Thermo Fisher Scientific position peaked at $1.14M in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.